Berwyn Clarke

Berwyn Clarke is an accomplished professional with extensive experience in the biotechnology and diagnostics sectors. Since September 2016, Berwyn has served as Chairman at Iceni Diagnostics, and has held the position of Non-Executive Director at PBD Biotech Limited since April 2019 following a tenure as Chief Executive from January 2014 to April 2019. Berwyn has also been Chairman of Glyconics Ltd since March 2014, focusing on innovative diagnostics using Infrared Spectroscopy for diseases like COPD and diabetes. Other notable roles include Non-Executive Director at NALIA Systems Ltd, Senior Scientific Advisor for ICAN Biomarkers Council until August 2023, and Non-Executive Director at Earlham Enterprises Limited. Berwyn's educational background includes a PhD in Medical Genetics from St Mary’s Hospital Medical School and a BSc(Hons) in Biochemistry from the University of Kent.